Moelis Capital Partners buys OmniSYS

Moelis Capital Partners has acquired OmniSYS from CIC Partners. Financial terms weren’t announced. Dallas-based OmniSYS provides medical claims reimbursement and compliance services for pharmacies and medical equipment providers. Bill Suddath and Ben Brown of Robert W. Baird advised OmniSYS.


November 21, 2013 – Dallas, TX: OmniSYS, LLC, the leader in medical claims reimbursement and compliance services for pharmacies and medical equipment providers, announced today that New York-based private equity firm Moelis Capital Partners (MCP) has acquired the company from CIC Partners, a private equity firm based in Dallas. Terms of the private sale were not disclosed.
“Today, OmniSYS is the nationally recognized market leader in government and private insurance reimbursement and compliance services for medical claims from retail and mail order pharmacies,” said Tricia Fringer, President and CEO of Dallas-based OmniSYS. “But even with our industry leading position, the changing health care landscape is rapidly expanding our market and opening up other strategic opportunities for OmniSYS, and Moelis Capital Partners sees that significant growth potential.”
Fringer explained that MCP provides OmniSYS substantial capital to grow strategically and organically, deep health care expertise, an expansive network of strategic relationships in the health care sector, and a shared vision for the potential of the company in a rapidly growing market. Fringer added that Moelis resources will help with strategic planning, business development, new product development and expanding capabilities for OmniSYS customers.
“We believe the OmniSYS team has done an outstanding job building and growing the company,” said Barbara Hill, the incoming chairperson of OmniSYS’ Board of Directors, and an Operating Partner at MCP focused on the healthcare sector. “The health care marketplace is moving strategically to grow in business areas where OmniSYS is already the market leader, and we believe with the planned level of investment and focus, the company will continue to be a valued partner to its customers as they expand, and will grow exponentially.”
Robert W. Baird & Co. acted as exclusive financial advisor to OmniSYS.
About OmniSYS
OmniSYS, headquartered in Dallas, TX, offers a comprehensive product portfolio that streamlines medical claims management for Medicare, Medicaid and Commercial Insurance for pharmacies, HME/DME providers, managed care organizations, and commercial retiree plans. OmniSYS’ proprietary billing system and comprehensive audit and compliance services are supported 24/7/365 by a world-class call center. OmniSYS exclusively offers a high touch patient prescription adherence program for Medicare beneficiaries, OmniLINK Advantage™, proven to increase adherence and improve medical outcomes. OmniSYS’ current programs support more than 35,000 Medicare Part B suppliers nationwide, processing over forty million Medicare claims annually. For more information, please visit
About Moelis Capital Partners
Moelis Capital Partners is a middle market private equity firm founded in 2007 in connection with the formation of Moelis & Company, a global investment bank. Moelis Capital Partners manages more than $800 million of committed private equity capital and specializes in traditional private equity investments in the middle market. For more information, please visit
About CIC Partners
CIC Partners is a middle-market private equity firm that invests in growth-oriented companies primarily in the food, restaurant, healthcare and energy industries. CIC manages the personal capital of its investment team, Operating Partners and strategic investors and seeks to partner with owner-operators, founders and management teams. CIC looks for opportunities where it can leverage the collective experience of its investment team and its Operating Partners, who are successful CEO’s and entrepreneurs, to guide, support and add value to portfolio companies. Based in Dallas, Texas, the firm has been generating wealth in private-equity investing for its investors and management teams for over 25 years. For additional information, please visit